Similar articles for PMID: 25862748

Year	Number of Results
1942	1
2009	1
2010	10
2011	10
2012	19
2013	18
2014	24
2015	32
2016	41
2017	34
2018	44
2019	33
2020	38
2021	30
2022	24
2023	11
2024	0

1

Diagnostic value of plasma and urinary 2-hydroxyglutarate to identify patients with isocitrate dehydrogenase-mutated glioma.

Lombardi G, Corona G, Bellu L, Della Puppa A, Pambuku A, Fiduccia P, Bertorelle R, Gardiman MP, D'Avella D, Toffoli G, Zagonel V. Lombardi G, et al. Oncologist. 2015 May;20(5):562-7. doi: 10.1634/theoncologist.2014-0266. Epub 2015 Apr 10. Oncologist. 2015. PMID: 25862748 Free PMC article.

2

Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomas.

Delahousse J, Verlingue L, Broutin S, Legoupil C, Touat M, Doucet L, Ammari S, Lacroix L, Ducreux M, Scoazec JY, Malka D, Paci A, Hollebecque A. Delahousse J, et al. Eur J Cancer. 2018 Feb;90:83-91. doi: 10.1016/j.ejca.2017.11.024. Epub 2018 Jan 4. Eur J Cancer. 2018. PMID: 29274619

3

Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma.

Nagashima H, Tanaka K, Sasayama T, Irino Y, Sato N, Takeuchi Y, Kyotani K, Mukasa A, Mizukawa K, Sakata J, Yamamoto Y, Hosoda K, Itoh T, Sasaki R, Kohmura E. Nagashima H, et al. Neuro Oncol. 2016 Nov;18(11):1559-1568. doi: 10.1093/neuonc/now090. Epub 2016 May 5. Neuro Oncol. 2016. PMID: 27154922 Free PMC article.

4

Comparative Value of 2-Hydroxyglutarate-to-Lipid and Lactate Ratio versus 2-Hydroxyglutarate Concentration on MR Spectroscopic Images for Predicting Isocitrate Dehydrogenase Mutation Status in Gliomas.

Suh CH, Kim HS, Park JE, Jung SC, Choi CG, Woo DC, Lee HB, Kim SJ. Suh CH, et al. Radiol Imaging Cancer. 2020 Jul 31;2(4):e190083. doi: 10.1148/rycan.2020190083. eCollection 2020 Jul. Radiol Imaging Cancer. 2020. PMID: 33778723 Free PMC article.

5

Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma.

Fathi AT, Nahed BV, Wander SA, Iafrate AJ, Borger DR, Hu R, Thabet A, Cahill DP, Perry AM, Joseph CP, Muzikansky A, Chi AS. Fathi AT, et al. Oncologist. 2016 Feb;21(2):214-9. doi: 10.1634/theoncologist.2015-0342. Epub 2016 Feb 1. Oncologist. 2016. PMID: 26834160 Free PMC article.

6

Tissue 2-Hydroxyglutarate and Preoperative Seizures in Patients With Diffuse Gliomas.

Ohno M, Hayashi Y, Aikawa H, Hayashi M, Miyakita Y, Takahashi M, Matsushita Y, Yoshida A, Satomi K, Ichimura K, Hamada A, Narita Y. Ohno M, et al. Neurology. 2021 Nov 23;97(21):e2114-e2123. doi: 10.1212/WNL.0000000000012893. Epub 2021 Oct 5. Neurology. 2021. PMID: 34610989

7

Isocitrate dehydrogenase 1 and 2 mutations, 2-hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemia.

Brunner AM, Neuberg DS, Wander SA, Sadrzadeh H, Ballen KK, Amrein PC, Attar E, Hobbs GS, Chen YB, Perry A, Connolly C, Joseph C, Burke M, Ramos A, Galinsky I, Yen K, Yang H, Straley K, Agresta S, Adamia S, Borger DR, Iafrate A, Graubert TA, Stone RM, Fathi AT. Brunner AM, et al. Cancer. 2019 Feb 15;125(4):541-549. doi: 10.1002/cncr.31729. Epub 2018 Nov 13. Cancer. 2019. PMID: 30422308 Free article.

8

2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size.

Capper D, Simon M, Langhans CD, Okun JG, Tonn JC, Weller M, von Deimling A, Hartmann C; German Glioma Network. Capper D, et al. Int J Cancer. 2012 Aug 1;131(3):766-8. doi: 10.1002/ijc.26425. Epub 2011 Nov 2. Int J Cancer. 2012. PMID: 21913188 Free article.

9

IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas.

Fujita Y, Nunez-Rubiano L, Dono A, Bellman A, Shah M, Rodriguez JC, Putluri V, Kamal AHM, Putluri N, Riascos RF, Zhu JJ, Esquenazi Y, Ballester LY. Fujita Y, et al. J Neurooncol. 2022 Sep;159(2):261-270. doi: 10.1007/s11060-022-04060-1. Epub 2022 Jul 11. J Neurooncol. 2022. PMID: 35816267 Free PMC article.

10

Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase.

Kalinina J, Ahn J, Devi NS, Wang L, Li Y, Olson JJ, Glantz M, Smith T, Kim EL, Giese A, Jensen RL, Chen CC, Carter BS, Mao H, He M, Van Meir EG. Kalinina J, et al. Clin Cancer Res. 2016 Dec 15;22(24):6256-6265. doi: 10.1158/1078-0432.CCR-15-2965. Epub 2016 Jun 23. Clin Cancer Res. 2016. PMID: 27340277 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

324 results

Results by year